£60.90

CRC Press The Third Histamine Receptor: Selective Ligands as Potential Therapeutic Agents in CNS Disorders

Price data last checked 27 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£61 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 64 days • 64 data points (No recent data available)

Historical
Generating forecast...
£60.90 £57.86 £59.07 £60.29 £61.51 £62.73 £63.95 14 March 2026 29 March 2026 14 April 2026 30 April 2026 16 May 2026

Price Distribution

Price distribution over 64 days • 1 price levels

Days at Price
64 days 0 16 32 48 64 £61 Days at Price

Price Analysis

Most common price: £61 (64 days, 100.0%)

Price range: £61 - £61

Price levels: 1 different prices over 64 days

Description

Reveals an Emerging Avenue of Potential Treatments for a Host of Challenging Diseases and Disorders The H3 receptor is known to play a major role in a range of CNS disorders, including those affecting cognitive functions such as ADHD and Alzheimer’s disease, as well as sleep disorders, obesity, epilepsy, schizophrenia, depression, and neurodegeneration. In light of dramatic advances in research at the molecular level, supported by impressive clinical studies, optimism remains high that an H3 receptor-related drug could hit the market soon. The Third Histamine Receptor: Selective Ligands as Potential Therapeutic Agents in CNS Disorders provides a thorough grounding in advances made over the last two decades. It brings together an elite group of 30 pioneering researchers. In writing about their own work, these scientists report on the cutting-edge investigations that are now being conducted across a variety of disciplines. This text is designed to aid researchers and inform those involved in the treatment and clinical aspects of a number of histamine-related diseases. Presents Several Disease-Specific Chapters Certainly, the most comprehensive and cutting-edge volume in the field, this text includes material drawn from groundbreaking research techniques and patent literature. Put together with great thought and passion, it is written to serve as a primary resource for anyone involved with or interested in the identification and localization of H3 receptors and the ligands being developed as therapeutic agents to treat a wide range of diseases including some that were once considered intractable. About the Author Vohora, Divya

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
16 December 2019
Listed Since
28 November 2019

Barcode

No barcode data available

Similar Products You Might Like

The Third Histamine Receptor: Selective Ligands as Potential Therapeutic Agents in CNS Disorders
99% match

The Third Histamine Receptor: Selective Ligands as Potential Therapeutic Agents in CNS Disorders

CRC Press

£202.09 10 Feb 2026
Humana Histamine Receptors: Preclinical and Clinical Aspects 28
97% match

Humana Histamine Receptors: Preclinical and Clinical Aspects 28

Humana

£112.81 01 May 2026
The Histamine H3 Receptor: A Target for New Drugs (Volume 30) (Pharmacochemistry Library, Volume 30)
97% match

The Histamine H3 Receptor: A Target for New Drugs (Volume 30) (Pharmacochemistry Library, Volume 30)

Elsevier

£139.36 10 Feb 2026
Histamine in Inflammation: 709 (Advances in Experimental Medicine and Biology, 709)
97% match

Histamine in Inflammation: 709 (Advances in Experimental Medicine and Biology, 709)

Springer

£106.45 10 Jun 2026
Biomedical Aspects of Histamine: Current Perspectives
97% match

Biomedical Aspects of Histamine: Current Perspectives

Springer

£135.08 15 May 2026
Histamine and Histamine Receptors in Health and Disease: 241 (Handbook of Experimental Pharmacology, 241)
97% match

Histamine and Histamine Receptors in Health and Disease: 241 (Handbook of Experimental Pharmacology, 241)

Springer

£164.22 12 Feb 2026
Histamine and Histamine Antagonists: 97 (Handbook of Experimental Pharmacology)
97% match

Histamine and Histamine Antagonists: 97 (Handbook of Experimental Pharmacology)

Springer

£82.22 12 May 2026
Biomedical Aspects of Histamine: Current Perspectives
97% match

Biomedical Aspects of Histamine: Current Perspectives

Springer

£139.50 05 Feb 2026
Humana Histamine Receptors as Drug Targets - Pharmacology Book
96% match

Humana Histamine Receptors as Drug Targets - Pharmacology Book

Humana

£104.18 10 May 2026
Histamine Intolerance: Histamine and Seasickness
95% match

Histamine Intolerance: Histamine and Seasickness

Springer

£63.18 09 Jan 2026
The Fundamentals of Hypersensitivities and Allergies Book
94% match

The Fundamentals of Hypersensitivities and Allergies Book

£109.48 18 Apr 2026
Multidisciplinary Approaches to Allergies: Advanced Topics in Science and Technology in China
94% match

Multidisciplinary Approaches to Allergies: Advanced Topics in Science and Technology in China

Springer

£29.82 08 Mar 2026
Allergy and Immunotoxicology in Occupational Health - The Next Step (Current Topics in Environmental Health and Preventive Medicine)
94% match

Allergy and Immunotoxicology in Occupational Health - The Next Step (Current Topics in Environmental Health and Preventive Medicine)

Springer

£76.81 27 Feb 2026
Monographs in Contact Allergy, Volume 4: Systemic Drugs
94% match

Monographs in Contact Allergy, Volume 4: Systemic Drugs

CRC Press

£155.00 25 Feb 2026
Allergy and Respiration: 921 (Advances in Experimental Medicine and Biology, 921)
94% match

Allergy and Respiration: 921 (Advances in Experimental Medicine and Biology, 921)

Springer

£103.12 25 Apr 2026
Beta-Arrestins: Methods and Protocols: 1957 (Methods in Molecular Biology, 1957)
94% match

Beta-Arrestins: Methods and Protocols: 1957 (Methods in Molecular Biology, 1957)

Humana

£104.40 12 Jun 2026
Mouse Models of Allergic Disease: Methods and Protocols: 1032 (Methods in Molecular Biology, 1032)
94% match

Mouse Models of Allergic Disease: Methods and Protocols: 1032 (Methods in Molecular Biology, 1032)

Humana

£84.24 04 Mar 2026
Allergy and Allergen Immunotherapy: New Mechanisms and Strategies
94% match

Allergy and Allergen Immunotherapy: New Mechanisms and Strategies

CRC Press

£76.70 03 Mar 2026
Allergy and Respiration: 921 (Advances in Experimental Medicine and Biology, 921)
94% match

Allergy and Respiration: 921 (Advances in Experimental Medicine and Biology, 921)

Springer

£101.05 07 Mar 2026
The G Protein-Coupled Receptors Handbook (Contemporary Clinical Neuroscience)
94% match

The G Protein-Coupled Receptors Handbook (Contemporary Clinical Neuroscience)

Humana

£147.44 10 Mar 2026
Histallay Hayfever & Allergy Relief Tablets, 180 Tablets, 120mg Fexofenadine, Antihistamine, 24hr Relief Acts Within 1hr, Relieves Hayfever, Pet, Dust and Mould Allergies (6 Month Supply)
94% match

Histallay Hayfever & Allergy Relief Tablets, 180 Tablets, 120mg Fexofenadine, Antihistamine, 24hr Relief Acts Within 1hr, Relieves Hayfever, Pet, Dust and Mould Allergies (6 Month Supply)

HISTALLAY

£49.39 20 Feb 2026
IgE, Mast Cells and the Allergic Response: Symposium Proceedings: 147 (Novartis Foundation Symposia)
94% match

IgE, Mast Cells and the Allergic Response: Symposium Proceedings: 147 (Novartis Foundation Symposia)

Wiley-Blackwell

£83.35 08 Mar 2026
Veterinary Allergy
93% match

Veterinary Allergy

Wiley-Blackwell

£119.72 27 Jan 2026
Muscarinic Receptor: From Structure to Animal Models: 107 (Neuromethods, 107)
93% match

Muscarinic Receptor: From Structure to Animal Models: 107 (Neuromethods, 107)

Humana

£86.14 09 Mar 2026